NS-062 is an orally active, irreversible targeted covalent inhibitor for EGFR , and exhibits antiproliferative efficacy in drug-resistant double mutated H1975 cell with an IC 50 of 0.19 μM. NS-062 exhibits antitumor efficacy in mouse H1975 xenograft model.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Signaling Pathways > EGFR
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。